Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.

Suppr

超能文献

作者信息

Swiryn S, Bauernfeind R A, Strasberg B, Palileo E, Iverson N, Levy P S, Rosen K M

出版信息

Am Heart J. 1982 Jul;104(1):43-50. doi: 10.1016/0002-8703(82)90639-1.

DOI:10.1016/0002-8703(82)90639-1

PMID:7090985

Abstract

摘要

相似文献

Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.

Am Heart J. 1982 Jul;104(1):43-50. doi: 10.1016/0002-8703(82)90639-1.

The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.

Circulation. 1983 Jan;67(1):30-7. doi: 10.1161/01.cir.67.1.30.

Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.

J Am Coll Cardiol. 1987 Apr;9(4):882-9. doi: 10.1016/s0735-1097(87)80246-2.

Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.

Circulation. 1982 Dec;66(6):1205-10. doi: 10.1161/01.cir.66.6.1205.

Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.

Circulation. 1978 Dec;58(6):986-97. doi: 10.1161/01.cir.58.6.986.

Initiation of ventricular tachycardia by reentry within the bundle branches. Implications for electrophysiologic testing of antiarrhythmic drugs.

Am J Cardiol. 1980 Apr;45(4):895-900. doi: 10.1016/0002-9149(80)90137-x.

Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.

Am J Cardiol. 1984 Aug 13;54(4):49B-54B. doi: 10.1016/0002-9149(84)90824-5.

Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.

Circulation. 1978 Dec;58(6):971-85. doi: 10.1161/01.cir.58.6.971.

Antiarrhythmic drug therapy for sustained ventricular tachycardia.

Heart Lung. 1984 Nov;13(6):614-22.

Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.

Am J Cardiol. 1978 Dec;42(6):1049-53. doi: 10.1016/0002-9149(78)90694-x.

引用本文的文献

Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.

Clin Cardiol. 2000 Mar;23(3):171-4. doi: 10.1002/clc.4960230308.

Programmed ventricular stimulation after myocardial infarction does not help reduce the risk of ventricular events.

Cardiovasc Drugs Ther. 1996 Nov;10(5):549-56. doi: 10.1007/BF00050995.

Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Drugs. 1987 Aug;34(2):151-87. doi: 10.2165/00003495-198734020-00001.

A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.

Cardiovasc Drugs Ther. 1989 Apr;3(2):155-61. doi: 10.1007/BF01883859.

Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Clin Pharmacokinet. 1991 Feb;20(2):151-66. doi: 10.2165/00003088-199120020-00006.

Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens.

Cardiovasc Drugs Ther. 1992 Apr;6(2):187-93. doi: 10.1007/BF00054570.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验